Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase

被引:18
作者
Fan, NS
Rank, KB
Poppe, SM
Tarpley, WG
Sharma, SK
机构
[1] UPJOHN CO,UPJOHN LABS,BIOCHEM,KALAMAZOO,MI 49001
[2] UPJOHN CO,UPJOHN LABS,CAN & INFECT DIS RES,KALAMAZOO,MI 49001
关键词
D O I
10.1021/bi9516440
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently we demonstrated that the p58 subunit of p68/p58 HIV-2 reverse transcriptase (RT) heterodimer, produced by processing of p68/p68 homodimer with recombinant HIV-2 protease, terminates at Met(484) [Fan, N., et al. (1995) J. Biol. Chem. 270, 13573-13579]. Here we describe purification and characterization of the p68/p58 heterodimer of recombinant HIV-2 RT. It exhibited both RT and RNase H activities, obeyed Michaelis-Menten kinetics, and was competitively inhibited by the DNA chain terminator ddTTP (K-i[app] = 305 +/- 20 nM). The HIV-2 RT-associated RNase H exhibited a marked preference for RNA hydrolysis from a HIV-1 gag-based heteropolymeric RNA/DNA hybrid in the presence of either Mg2+ or Mn2+, compared to the [H-3]poly(rA). poly(dT) or [H-3]poly(rG). poly(dC) homopolymeric substrates. Relative to HIV-1 RT, the RNase H activity of HIV-2 RT was only 5% toward the [H-3]poly(rA) poly(dT) in the presence of Mg2+. The size distribution of products generated from [H-3]poly(rA). poly(dT) by HIV-2 RT-associated RNase H was markedly distinct from that of HIV-1 RT in the presence of Mg2+ Or Mn2+. The p68/p58 HIV-2 RT heterodimer, produced by specific cleavage using HIV-2 protease, should be useful for inhibition and biophysical studies aimed at discovering and designing drugs directed toward HIV-2.
引用
收藏
页码:1911 / 1917
页数:7
相关论文
共 32 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]  
CHANDRA P, 1985, CANCER RES, V45, P4677
[3]  
CHATTOPADHYAY D, 1992, J BIOL CHEM, V267, P14227
[4]   ISOLATION OF A NEW HUMAN RETROVIRUS FROM WEST-AFRICAN PATIENTS WITH AIDS [J].
CLAVEL, F ;
GUETARD, D ;
BRUNVEZINET, F ;
CHAMARET, S ;
REY, MA ;
SANTOSFERREIRA, MO ;
LAURENT, AG ;
DAUGUET, C ;
KATLAMA, C ;
ROUZIOUX, C ;
KLATZMANN, D ;
CHAMPALIMAUD, JL ;
MONTAGNIER, L .
SCIENCE, 1986, 233 (4761) :343-346
[5]   MOLECULAR-CLONING AND POLYMORPHISM OF THE HUMAN IMMUNE-DEFICIENCY VIRUS TYPE-2 [J].
CLAVEL, F ;
GUYADER, M ;
GUETARD, D ;
SALLE, M ;
MONTAGNIER, L ;
ALIZON, M .
NATURE, 1986, 324 (6098) :691-695
[6]   HIV RESISTANCE TO REVERSE-TRANSCRIPTASE INHIBITORS [J].
DECLERCQ, E .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (02) :155-169
[7]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 REVERSE-TRANSCRIPTASE [J].
DEVICO, AL ;
COPELAND, TD ;
VERONESE, FD ;
OROSZLAN, S ;
GALLO, RC ;
SARNGADHARAN, MG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (01) :51-60
[8]  
EVANS DB, 1994, J BIOL CHEM, V269, P21741
[9]  
FAN N, 1995, FEBS LETT, V359, P33
[10]  
FAN NS, 1995, J BIOL CHEM, V270, P13573